𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Radiotherapy for localized low grade non-hodgkin's lymphoma: the role of combined chemotherapy and the prognostic factor

✍ Scribed by Kazushige Tsutsui; Yuta Shibamoto; Mitsuyuki Abe

Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
207 KB
Volume
21
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Primary non-hodgkin's lymphoma of the na
Primary non-hodgkin's lymphoma of the nasal cavity : Prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy
✍ Ye-Xiong Li; Philippe A. Coucke; Jian-Ying Li; Da-Zhong Gu; Xin-Fan Liu; Li-Qian πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 101 KB πŸ‘ 2 views

## BACKGROUND. This study was conducted to determine whether the paranasal extension of a primary non-Hodgkin's lymphoma (NHL) of the nasal cavity has any deleterious effect on patient outcome. ## METHODS. One hundred and seventy-five patients with previously untreated nasal NHL were reviewed.

Role and prognostic significance of the
Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma
✍ Adi Broyde; Olga Boycov; Yulia Strenov; Elimelech Okon; Ofer Shpilberg; Osnat Ba πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 202 KB πŸ‘ 2 views

## Abstract Expression of Ki‐67, a nuclear antigen protein present in all cycling cells, is used to determine the growth fraction of tumors. The aim of this study was to evaluate the role and prognostic significance of the Ki‐67 proliferation index (PI) in non‐Hodgkin's lymphoma. Ki‐67 was assayed

Prognostic factors for patients with dif
Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: Experience of the non-Hodgkin's lymphoma pathologic classification project
✍ Simon, Richard ;Durrleman, Sylvain ;Hoppe, Richard T. ;Bonadonna, Gianni ;Bloomf πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 678 KB

## Abstract Prognostic factors for long‐term survival of 312 patients with diffuse large cell or immunoblastic non‐Hodgkin's lymphoma are presented based on analysis of the multi‐institution clinicopathologic study sponsored by the National Cancer Institute. At the time of analysis, 75% of the pati